GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » 1-Year ROIIC %

VRAX (Virax Biolabs Group) 1-Year ROIIC % : 291.98% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Virax Biolabs Group's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was 291.98%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Virax Biolabs Group's 1-Year ROIIC % or its related term are showing as below:

VRAX's 1-Year ROIIC % is ranked better than
86.29% of 1422 companies
in the Biotechnology industry
Industry Median: -11.235 vs VRAX: 291.98

Virax Biolabs Group 1-Year ROIIC % Historical Data

The historical data trend for Virax Biolabs Group's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virax Biolabs Group 1-Year ROIIC % Chart

Virax Biolabs Group Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
1-Year ROIIC %
- - - - -37.23

Virax Biolabs Group Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only -609.66 - -436.38 -37.23 291.98

Competitive Comparison of Virax Biolabs Group's 1-Year ROIIC %

For the Biotechnology subindustry, Virax Biolabs Group's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virax Biolabs Group's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's 1-Year ROIIC % falls into.



Virax Biolabs Group 1-Year ROIIC % Calculation

Virax Biolabs Group's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -6.1425 (Sep. 2024) - -6.998 (Sep. 2023) )/( 1.689 (Sep. 2024) - 1.396 (Sep. 2023) )
=0.8555/0.293
=291.98%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Virax Biolabs Group  (NAS:VRAX) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Virax Biolabs Group 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Virax Biolabs Group Business Description

Traded in Other Exchanges
N/A
Address
Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.